Midas Capital, based in Philadelphia, focuses on private equity investments. The firm, founded by Josh Kopelman, primarily targets Series B funding rounds, demonstrating a preference for companies with established traction and growth potential.
Notable in Midas Capital's portfolio is Corsair Pharma, which has raised $23 million to date. Josh Kopelman, a key decision-maker, brings his entrepreneurial experience to the firm's investment strategy. Midas Capital likely offers strategic guidance and industry connections to its portfolio companies, leveraging Kopelman's background in the tech and investment sectors.
Midas Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies1
Current Portfolio Count1
Top Investment Stages
Series B1 (100.0%)
Stage Mix
Series B 100%
Concentration shown as share of disclosed investments by stage.
